Scientists Discover How Blood Vessels Control Brain and Heart Cell Performance
New research reveals how tiny blood vessels and cellular powerhouses work together to control brain and heart function.
6616 articles
New research reveals how tiny blood vessels and cellular powerhouses work together to control brain and heart function.
Enlicitide, the first oral PCSK9 inhibitor, dramatically reduced LDL cholesterol levels in cardiovascular disease patients over 52 weeks.
New research reveals how GlyH-101 blocks CFTR channels through both external and internal pathways, advancing cystic fibrosis treatment.
New research reveals how individualized lipid therapy based on stroke type and genetics could dramatically improve prevention outcomes.
Andean mice developed genetic adaptations preventing heart damage at extreme altitudes, offering insights for cardiovascular health.
Lowering LDL cholesterol below 40 mg/dL reduced major cardiovascular events by 31% in stroke survivors without increasing bleeding risk.
Researchers create personalized heart models to predict dangerous rhythm problems from chemotherapy before treatment begins.
Enlicitide, a daily pill, dramatically reduced LDL cholesterol in patients with familial hypercholesterolemia beyond what statins alone achieved.
Major study shows cholesterol-lowering drug prevents heart attacks and strokes in people without prior cardiovascular disease.
Revolutionary cell therapy achieves drug-free remission in patients with severe myasthenia gravis, an autoimmune muscle disorder.
Scientists create advanced heart simulation showing how sympathetic nervous system activity can cause life-threatening irregular heartbeats.
Systematic review reveals younger RA patients achieve higher remission rates and better outcomes with biologic therapies than older patients.